Weniger Nebenwirkungen, bessere Wirksamkeit - einBLICK - Online-Magazin der Universität Würzburg
Stuhler - Names Encyclopedia
Loop | Hannes Neuweiler
Gernot Stuhler's research works | University of Wuerzburg, Würzburg (JMU) and other places
ABOUT US - 99designs-5d6bbd5555df1s Webseite!
Updated Results from the Bridge Trial: Long-Term Survival and Impact of Donor Availability – Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML -
Gernot Stuhler's research works | University of Wuerzburg, Würzburg (JMU) and other places
Hemibodies vernichten Krebszellen - Kampf gegen Krebs e.V.
Stuhler - Names Encyclopedia
Anti‐CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial - Schetelig - 2019 - British Journal of Haematology -
PDF) Erratum: Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo | William Sessa - Academia.edu
Allogeneic Stem Cell Transplantation in Multiple Myeloma Relapsed after Autograft: A Multicenter Retrospective Study Based on Do
Pre-clinical and Early Clinical Experience Using Dendritic Cells to Treat Human Malignancy
Cancer Immune Therapy: Current and Future Strategies - Google Books
Der Initiator Prof. Dr. Gernot Stuhler ist zurück am Universitätsklinikum
On-target restoration of a split T cell-engaging antibody for precision immunotherapy | Nature Communications
12) Patent Application Publication (10) Pub. No.: US 2015/0079093 A1
Hemibodies – a new antibody format for cancer immunotherapy - BMBF GO-Bio
On-target restoration of a split T cell-engaging antibody for precision immunotherapy. - Abstract - Europe PMC
